Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-17-043261

Options or other derivatives

  • Director acquired 243,724 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Alleva Lawrence M Director 2017-07-03 Grant or award · Option to purchase Ordinary Shares +243,724 243,724 D
Loading xslF345X03/a4.xml…